Skip to main content

DermTech Joins Skin Products Company in Genetic Studies of Acne

NEW YORK (GenomeWeb News) - DermTech, a molecular diagnostics company focused on skin diseases, said today that it is partnering with dermatology company Stiefel Laboratories to investigate the molecular causes of acne.
 
The companies have agreed to use DermTech’s Epidermal Genetic Information Retrieval, or EGIR, technology and its gene expression assays to study genes that are involved in causing acne. Stiefel hopes to use the data from this feasibility research to develop targeted acne treatments.
 
Under the agreement, DermTech will provide Stiefel with the EGIR skin-sampling technology, which uses adhesives that are applied to the patients' epidermis skin to collect RNA. DermTech said it will analyze the samples Stiefel collects using quantitative reverse transcriptase-PCR.
 
DermTech CEO George Schwartz said his company is “confident that we will be able to help confirm and identify the molecular causes of acne."

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.